IOS Press

Medical research

Memory loss reversed or abated in those with cognitive decline

Cognitive decline is a major concern of the aging population. Already, Alzheimer's disease affects approximately 5.4 million Americans and 30 million people globally. Without effective prevention and treatment, the prospects ...

Neuroscience

Three stages to COVID-19 brain damage identified by neurologists

The Journal of Alzheimer's Disease has just published a paper with a comprehensive review of the COVID-19's effect on the nervous system which classifies brain damage caused by COVID-19 into three stages. One of the authors, ...

Parkinson's & Movement disorders

Growth factors and Parkinson's disease—Where next?

Growth factors such as glial cell line-derived neurotrophic factor (GDNF) were initially thought to be exciting new treatments for Parkinson's disease (PD), but trials have been disappointing. A panel of prominent leaders ...

page 10 from 40